Project Details
| Short title | BO44157 |
|---|---|
| Acronym | BO44157 |
| Status | Active |
| Effective start/end date | 5/05/23 → 17/04/28 |
CTU: A Phase II, Randomized, Multicenter, Open-label, Controlled Study of RO7247669 Alone or in Combination with Tiragolumab versus Atezolizumab in Patients with Previously Untreated Locally Advanced or Metastitic Urothelial Cancer who are Ineligible for Platinum-containing Chemotherapy
- Zhang, Alison (Primary Chief Investigator)
- Contacos, Christine (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
- Morrisroe, Emma (Clinical Trial Unit Staff)
- Keshiya, Shikara (Clinical Trial Unit Staff)
- Chester, Catherine (Clinical Trial Unit Staff)
Project: Research